Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma
American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)65355-2
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 1999
Authors
Publisher
Elsevier BV